“A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide” has been added to your cart. View cart
This product is the full issue of Psychopharmacology Bulletin VOL 47 No. 3. Upon purchase, you will receive a single downloadable PDF file with all this issues articles stacked from front cover to back cover.